First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.
First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.
The main topics of this session are the fundamental ideas and developing procedures for guaranteeing medication safety during the course of the product lifecycle. With a focus on enhancing patient outcomes and reducing risk, it will address regulatory requirements, real-world evidence, data-driven ways to monitor adverse events, and advancements in pharmacovigilance systems.